AI outperforms doctors in spotting dangerous colon polyps?
NCT ID NCT04921488
First seen May 18, 2026 · Last updated May 30, 2026 · Updated 1 time
Summary
This study tested an artificial intelligence (AI) system called CAD EYE to see if it could accurately predict whether colon polyps are cancerous during a colonoscopy. Researchers compared the AI's predictions to those of doctors and the final lab results. The goal was to improve screening for colorectal cancer and reduce unnecessary costs and procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU d'Angers
Angers, 49100, France
-
Centre Hospitalier Universitaire de Bordeaux
Talence, 33404, France
-
Hopital Américain
Neuilly-sur-Seine, 92200, France
-
Hôpital Européen Georges Pompidou
Paris, 75015, France
-
Hôpital Saint Antoine
Paris, 75012, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.